The Rising Low Molecular Weight Heparin Market is driven by Increasing Prevalence of Chronic Diseases
Paragraph: Low molecular weight heparin (LMWH) is a class of anticoagulant medications that have a smaller size than standard heparin. LMWHs have certain advantages over standard heparin such as improved bioavailability and a longer plasma half-life which provides better coverage throughout the dosing interval. LMWHs are commonly used for stroke prevention in atrial fibrillation, prevention and treatment of deep vein thrombosis and pulmonary embolism and management of acute coronary syndromes. The global LMWH market is growing rapidly owing to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases and metabolic disorders that require LMWH for effective treatment and management.
The global low molecular weight heparin market is estimated to be valued at US$ 3,903.1 million in 2022 and is expected to exhibit a CAGR of 6.7% during the forecast period (2022-2030).
Key Takeaways
Key players operating in the LMWH market are Getir, Gorillas, Gopuff, Just Eat Takeaway, Delivery Hero, Jokr, Flink, Zapp, Uber Eats, Wolt, Bolt, Deliveroo. Key players in the LMWH market are focusing on production capacity expansion and new product launches to strengthen their market position.
The growing prevalence of chronic medical conditions requiring anticoagulant therapy is driving the demand for Low Molecular Weight Heparin Market Demand. Rising geriatric population who are more prone to diseases such as cancer and heart conditions is a major factor contributing to the increase in demand for LMWH.
Get More Insights on- Low Molecular Weight Heparin Market
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian